Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Polyplus

    - PMLiVE

    Eli Lilly and Creyon Bio enter oligonucleotide therapy partnership worth over $1bn

    The companies will aim to develop RNA-targeted drugs for a broad range of diseases

    - PMLiVE

    AstraZeneca to expand cell therapy capabilities with $1bn EsoBiotec acquisition

    The biotech’s ENaBL platform enables cell therapies to be administered through an IV injection

    - PMLiVE

    Bristol Myers Squibb reveals plans to double number of drugs in registrational trials

    The drugmaker expects to expand its research pipeline from six to 12 over next 18 months

    - PMLiVE

    Eli Lilly to acquire Sigilon in deal worth over $300m

    The companies have been working together since 2018 on cell therapies for type 1 diabetes

    - PMLiVE

    Sartorius signs agreement to acquire Polyplus for €2.4bn

    The deal is expected to close during the third quarter of this year

    - PMLiVE

    bluebird bio reveals plans to launch two gene therapies

    Both therapies were endorsed by the US FDA Cell Tissue & Gene Therapy Advisory Committee

    - PMLiVE

    Merck KGaA announces launch of start-up collaboration programme in Asia

    The selected companies will receive up to €100,000 in financial assistance, as well as mentoring from Merck

    - PMLiVE

    Bespoke Gene Therapy Consortium created to collaborate in development of rare disease gene therapies

    Ten pharma companies will team up with the FDA, NIH and five non-profits to accelerate the development of gene therapies to treat rare inherited diseases

    - PMLiVE

    Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more

    A rapid round up of pharma, biotech and healthcare news

    Novartis building

    Novartis signs cell therapy deal with Regenerex

    Involves platform that could allow transplant patients to live without lifelong immunosuppression

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links